CURX
Curanex·NASDAQ
--
--(--)
--
--(--)
CURX fundamentals
During Q3 2025, Curanex (CURX) reported revenue of --, a YoY change of 0.00%. Net income was -954.06K, a YoY change of -946.51%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Operating Expenses | 84 -- | 12.67K -- | 80.20K -- | 44.20K -- | 93.30K +110965.48% | 147.37K +1063.02% | 137.45K +71.38% | 57.66K +30.45% | 951.33K +919.70% | 1.29M -- |
Selling, General and Administrative Expenses | 84 -- | 12.67K -- | 80.20K -- | 44.20K -- | 93.30K +110965.48% | 72.69K +473.67% | 137.45K +71.38% | 57.66K +30.45% | 273.85K +193.53% | 541.65K -- |
General and Administrative Expenses | 6.63K -- | 12.67K -- | 80.20K -- | 44.20K -- | 93.30K +1307.80% | 72.69K +473.67% | 137.45K +71.38% | 57.66K +30.45% | 273.85K +193.53% | 541.65K -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 677.47K -- | -- -- |
Loss on Impairment of Other Assets | -- -- | 0 -- | -- -- | -- -- | -- -- | 74.68K -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -84 -- | -12.67K -- | -80.20K -- | -44.20K -- | -93.30K -110965.48% | -147.37K -1063.02% | -137.45K -71.38% | -57.66K -30.45% | -951.33K -919.70% | -1.29M -- |
Non-Operating Income (Loss) | 100 -- | 0 -- | 0 -- | 0 -- | 2.13K +2029.00% | 1.43K -- | -131 -- | -2.69K -- | -2.73K -228.32% | -4.12K -- |
Other Non-Operating Income (Loss) | 100 -- | 0 -- | 0 -- | 0 -- | 2.13K +2029.00% | 1.43K -- | 1.23K -- | 403 -- | 1.36K -36.21% | 4.41K -- |
Net Interest Expense | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 1.36K -- | 3.09K -- | 4.09K -- | -- -- |
Interest Expense | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 1.36K -- | 3.09K -- | 4.09K -- | -- -- |
Pretax Income From Continuing Operations | 16 -- | -12.67K -- | -80.20K -- | -44.20K -- | -91.17K -569887.50% | -137.16K -982.50% | -137.58K -71.55% | -60.35K -36.53% | -954.06K -946.51% | -1.29M -- |
Net Income | 16 -- | -12.67K -- | -80.20K -- | -44.20K -- | -91.17K -569887.50% | -137.16K -982.50% | -137.58K -71.55% | -60.35K -36.53% | -954.06K -946.51% | -1.29M -- |
Net Income Attributable to Owners of the Company | 16 -- | -12.67K -- | -80.20K -- | -44.20K -- | -91.17K -569887.50% | -145.94K -1051.76% | -137.58K -71.55% | -60.35K -36.53% | -954.06K -946.51% | -1.30M -- |
Net Income Attributable to Common Stockholders | 16 -- | -12.67K -- | -80.20K -- | -44.20K -- | -91.17K -569887.50% | -145.94K -1051.76% | -137.58K -71.55% | -60.35K -36.53% | -954.06K -946.51% | -1.30M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -44.20K -- | -- -- | -- -- | -- -- | -60.35K -36.53% | -- -- | -- -- |
Basic EPS | -- -- | -- -- | -0.13 -- | -0.02 -- | -0.04 -- | -- -- | -0.01 +92.31% | 0 +100.00% | -0.04 -- | -- -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -0.13 -- | -0.02 -- | -0.04 -- | -- -- | -0.01 +92.31% | 0 +100.00% | -0.04 -- | -- -- |
Diluted EPS | -- -- | -- -- | -0.13 -- | -0.02 -- | -0.04 -- | -- -- | -0.01 +92.31% | 0 +100.00% | -0.04 -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -0.13 -- | -0.02 -- | -0.04 -- | -- -- | -0.01 +92.31% | 0 +100.00% | -0.04 -- | -- -- |
You can ask Aime
Did Curanex beat or miss consensus estimates last quarter?What is the market's earnings forecast for Curanex next quarter?What does Curanex do and what are its main business segments?What is Curanex's gross profit margin?What factors drove the changes in Curanex's revenue and profit?What is the revenue and EPS growth rate for Curanex year over year?What were the key takeaways from Curanex’s earnings call?What were the key takeaways from Curanex's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
